nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PTGS2—Dapsone—malaria	0.124	0.196	CbGbCtD
Betamethasone—CYP3A4—Clindamycin—malaria	0.109	0.172	CbGbCtD
Betamethasone—CYP3A4—Sulfadiazine—malaria	0.0626	0.099	CbGbCtD
Betamethasone—ABCB1—Quinine—malaria	0.0538	0.0851	CbGbCtD
Betamethasone—CYP3A4—Artemether—malaria	0.0532	0.0842	CbGbCtD
Betamethasone—CYP3A4—Proguanil—malaria	0.05	0.0792	CbGbCtD
Betamethasone—CYP3A4—Doxycycline—malaria	0.0474	0.075	CbGbCtD
Betamethasone—ABCB1—Quinidine—malaria	0.0473	0.0748	CbGbCtD
Betamethasone—CYP3A4—Quinine—malaria	0.0322	0.051	CbGbCtD
Betamethasone—CYP3A4—Quinidine—malaria	0.0283	0.0448	CbGbCtD
Betamethasone—CYP3A4—Dapsone—malaria	0.0244	0.0387	CbGbCtD
Betamethasone—PLA2G1B—blood plasma—malaria	0.0114	0.107	CbGeAlD
Betamethasone—PLA2G1B—hematopoietic system—malaria	0.00632	0.0592	CbGeAlD
Betamethasone—NR3C2—blood plasma—malaria	0.00566	0.053	CbGeAlD
Betamethasone—PLA2G1B—kidney—malaria	0.00518	0.0485	CbGeAlD
Betamethasone—PLA2G1B—digestive system—malaria	0.00439	0.0411	CbGeAlD
Betamethasone—PLA2G1B—blood—malaria	0.00419	0.0392	CbGeAlD
Betamethasone—NR3C2—saliva-secreting gland—malaria	0.00328	0.0307	CbGeAlD
Betamethasone—NR3C2—hematopoietic system—malaria	0.00313	0.0293	CbGeAlD
Betamethasone—NR3C1—blood plasma—malaria	0.00303	0.0284	CbGeAlD
Betamethasone—PTGS2—endothelium—malaria	0.00296	0.0277	CbGeAlD
Betamethasone—PGR—hematopoietic system—malaria	0.00291	0.0272	CbGeAlD
Betamethasone—PTGS2—blood plasma—malaria	0.00263	0.0246	CbGeAlD
Betamethasone—CYP19A1—hematopoietic system—malaria	0.00262	0.0245	CbGeAlD
Betamethasone—PLA2G1B—brain—malaria	0.0026	0.0243	CbGeAlD
Betamethasone—NR3C2—kidney—malaria	0.00256	0.024	CbGeAlD
Betamethasone—CYP3A4—blood plasma—malaria	0.0023	0.0215	CbGeAlD
Betamethasone—NR3C2—digestive system—malaria	0.00218	0.0204	CbGeAlD
Betamethasone—NR3C2—blood—malaria	0.00207	0.0194	CbGeAlD
Betamethasone—PGR—blood—malaria	0.00193	0.018	CbGeAlD
Betamethasone—NR3C1—saliva-secreting gland—malaria	0.00176	0.0165	CbGeAlD
Betamethasone—CYP19A1—blood—malaria	0.00173	0.0162	CbGeAlD
Betamethasone—NR3C1—hematopoietic system—malaria	0.00168	0.0157	CbGeAlD
Betamethasone—ABCB1—blood plasma—malaria	0.00162	0.0152	CbGeAlD
Betamethasone—NR3C2—liver—malaria	0.00162	0.0152	CbGeAlD
Betamethasone—PTGS2—hematopoietic system—malaria	0.00145	0.0136	CbGeAlD
Betamethasone—NR3C1—kidney—malaria	0.00138	0.0129	CbGeAlD
Betamethasone—CYP19A1—liver—malaria	0.00136	0.0127	CbGeAlD
Betamethasone—NR3C2—brain—malaria	0.00129	0.012	CbGeAlD
Betamethasone—CYP3A4—hematopoietic system—malaria	0.00127	0.0119	CbGeAlD
Betamethasone—PGR—brain—malaria	0.0012	0.0112	CbGeAlD
Betamethasone—PTGS2—kidney—malaria	0.00119	0.0111	CbGeAlD
Betamethasone—NR3C1—digestive system—malaria	0.00117	0.0109	CbGeAlD
Betamethasone—Ecchymosis—Quinidine barbiturate—malaria	0.00112	0.00444	CcSEcCtD
Betamethasone—NR3C1—blood—malaria	0.00111	0.0104	CbGeAlD
Betamethasone—Pulmonary oedema—Quinidine barbiturate—malaria	0.00111	0.00437	CcSEcCtD
Betamethasone—CYP19A1—brain—malaria	0.00108	0.0101	CbGeAlD
Betamethasone—NR3C1—bone marrow—malaria	0.00108	0.0101	CbGeAlD
Betamethasone—Dermatitis bullous—Clindamycin—malaria	0.00107	0.00421	CcSEcCtD
Betamethasone—Visual disturbance—Quinidine—malaria	0.00106	0.00416	CcSEcCtD
Betamethasone—Visual disturbance—Quinine—malaria	0.00106	0.00416	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Clindamycin—malaria	0.00105	0.00416	CcSEcCtD
Betamethasone—Dermatitis bullous—Quinine—malaria	0.00105	0.00413	CcSEcCtD
Betamethasone—Dermatitis bullous—Quinidine—malaria	0.00105	0.00413	CcSEcCtD
Betamethasone—CYP3A4—kidney—malaria	0.00104	0.00974	CbGeAlD
Betamethasone—Neuropathy peripheral—Sulfadiazine—malaria	0.00103	0.00408	CcSEcCtD
Betamethasone—Psychotic disorder—Dapsone—malaria	0.00103	0.00406	CcSEcCtD
Betamethasone—PTGS2—digestive system—malaria	0.00101	0.00946	CbGeAlD
Betamethasone—Nervous system disorder—Proguanil—malaria	0.000994	0.00392	CcSEcCtD
Betamethasone—Cardiac arrest—Clindamycin—malaria	0.000969	0.00383	CcSEcCtD
Betamethasone—Anorexia—Proguanil—malaria	0.000966	0.00381	CcSEcCtD
Betamethasone—PTGS2—blood—malaria	0.000962	0.00901	CbGeAlD
Betamethasone—Visual disturbance—Quinidine barbiturate—malaria	0.000952	0.00376	CcSEcCtD
Betamethasone—Cardiac arrest—Quinidine—malaria	0.000951	0.00375	CcSEcCtD
Betamethasone—Cardiac arrest—Quinine—malaria	0.000951	0.00375	CcSEcCtD
Betamethasone—Dermatitis bullous—Quinidine barbiturate—malaria	0.000944	0.00373	CcSEcCtD
Betamethasone—Hallucination—Sulfadiazine—malaria	0.000942	0.00372	CcSEcCtD
Betamethasone—Dry skin—Clindamycin—malaria	0.000934	0.00369	CcSEcCtD
Betamethasone—PTGS2—bone marrow—malaria	0.000931	0.00872	CbGeAlD
Betamethasone—Anaphylactoid reaction—Pentoxifylline—malaria	0.000931	0.00367	CcSEcCtD
Betamethasone—Muscular weakness—Dapsone—malaria	0.000929	0.00367	CcSEcCtD
Betamethasone—Lethargy—Quinidine barbiturate—malaria	0.000921	0.00363	CcSEcCtD
Betamethasone—ABCB1—hematopoietic system—malaria	0.000898	0.00841	CbGeAlD
Betamethasone—Affect lability—Quinidine barbiturate—malaria	0.000888	0.00351	CcSEcCtD
Betamethasone—CYP3A4—digestive system—malaria	0.000883	0.00826	CbGeAlD
Betamethasone—Muscular weakness—Quinine—malaria	0.000882	0.00348	CcSEcCtD
Betamethasone—Muscular weakness—Quinidine—malaria	0.000882	0.00348	CcSEcCtD
Betamethasone—Decreased appetite—Proguanil—malaria	0.000881	0.00348	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Proguanil—malaria	0.000875	0.00345	CcSEcCtD
Betamethasone—NR3C1—liver—malaria	0.000869	0.00814	CbGeAlD
Betamethasone—Irritability—Quinidine barbiturate—malaria	0.000861	0.0034	CcSEcCtD
Betamethasone—Cardiac arrest—Quinidine barbiturate—malaria	0.000858	0.00339	CcSEcCtD
Betamethasone—Mood swings—Quinidine barbiturate—malaria	0.000855	0.00337	CcSEcCtD
Betamethasone—CYP3A4—blood—malaria	0.000841	0.00787	CbGeAlD
Betamethasone—Gastrointestinal pain—Proguanil—malaria	0.000829	0.00327	CcSEcCtD
Betamethasone—Vomiting—Pyrimethamine—malaria	0.000827	0.00326	CcSEcCtD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—FCGR2B—malaria	0.000822	0.101	CbGpPWpGaD
Betamethasone—Body temperature increased—Proguanil—malaria	0.000801	0.00316	CcSEcCtD
Betamethasone—Abdominal pain—Proguanil—malaria	0.000801	0.00316	CcSEcCtD
Betamethasone—Neuropathy peripheral—Dapsone—malaria	0.000796	0.00314	CcSEcCtD
Betamethasone—Muscular weakness—Quinidine barbiturate—malaria	0.000796	0.00314	CcSEcCtD
Betamethasone—PTGS2—liver—malaria	0.000752	0.00705	CbGeAlD
Betamethasone—Vertigo—Sulfadiazine—malaria	0.000741	0.00292	CcSEcCtD
Betamethasone—ABCB1—kidney—malaria	0.000736	0.00689	CbGeAlD
Betamethasone—Convulsion—Sulfadiazine—malaria	0.000714	0.00282	CcSEcCtD
Betamethasone—Bradycardia—Quinidine—malaria	0.000704	0.00278	CcSEcCtD
Betamethasone—Bradycardia—Quinine—malaria	0.000704	0.00278	CcSEcCtD
Betamethasone—Haemoglobin—Quinine—malaria	0.000695	0.00274	CcSEcCtD
Betamethasone—Haemoglobin—Quinidine—malaria	0.000695	0.00274	CcSEcCtD
Betamethasone—Diarrhoea—Proguanil—malaria	0.000693	0.00274	CcSEcCtD
Betamethasone—Haemorrhage—Quinine—malaria	0.000692	0.00273	CcSEcCtD
Betamethasone—Haemorrhage—Quinidine—malaria	0.000692	0.00273	CcSEcCtD
Betamethasone—NR3C1—brain—malaria	0.00069	0.00646	CbGeAlD
Betamethasone—Conjunctivitis—Pentoxifylline—malaria	0.000675	0.00266	CcSEcCtD
Betamethasone—Anaphylactic shock—Sulfadiazine—malaria	0.000673	0.00266	CcSEcCtD
Betamethasone—Visual impairment—Quinidine—malaria	0.000667	0.00263	CcSEcCtD
Betamethasone—Visual impairment—Quinine—malaria	0.000667	0.00263	CcSEcCtD
Betamethasone—Thrombocytopenia—Sulfadiazine—malaria	0.000659	0.0026	CcSEcCtD
Betamethasone—CYP3A4—liver—malaria	0.000658	0.00616	CbGeAlD
Betamethasone—Eye disorder—Quinidine—malaria	0.000646	0.00255	CcSEcCtD
Betamethasone—Eye disorder—Quinine—malaria	0.000646	0.00255	CcSEcCtD
Betamethasone—Vomiting—Proguanil—malaria	0.000644	0.00254	CcSEcCtD
Betamethasone—Anorexia—Sulfadiazine—malaria	0.000641	0.00253	CcSEcCtD
Betamethasone—Rash—Proguanil—malaria	0.000639	0.00252	CcSEcCtD
Betamethasone—Dermatitis—Proguanil—malaria	0.000638	0.00252	CcSEcCtD
Betamethasone—Bradycardia—Quinidine barbiturate—malaria	0.000636	0.00251	CcSEcCtD
Betamethasone—Headache—Proguanil—malaria	0.000635	0.00251	CcSEcCtD
Betamethasone—Erythema—Dapsone—malaria	0.000635	0.0025	CcSEcCtD
Betamethasone—Haemoglobin—Quinidine barbiturate—malaria	0.000627	0.00248	CcSEcCtD
Betamethasone—Haemoglobin—Pentoxifylline—malaria	0.000626	0.00247	CcSEcCtD
Betamethasone—ABCB1—digestive system—malaria	0.000625	0.00585	CbGeAlD
Betamethasone—Haemorrhage—Quinidine barbiturate—malaria	0.000624	0.00246	CcSEcCtD
Betamethasone—Haemorrhage—Pentoxifylline—malaria	0.000623	0.00246	CcSEcCtD
Betamethasone—Hallucination—Quinidine barbiturate—malaria	0.000621	0.00245	CcSEcCtD
Betamethasone—Erythema—Clindamycin—malaria	0.000614	0.00242	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000613	0.00242	CcSEcCtD
Betamethasone—Insomnia—Sulfadiazine—malaria	0.000608	0.0024	CcSEcCtD
Betamethasone—Erythema—Quinidine—malaria	0.000602	0.00238	CcSEcCtD
Betamethasone—Erythema—Quinine—malaria	0.000602	0.00238	CcSEcCtD
Betamethasone—Nausea—Proguanil—malaria	0.000602	0.00238	CcSEcCtD
Betamethasone—Visual impairment—Quinidine barbiturate—malaria	0.000602	0.00237	CcSEcCtD
Betamethasone—PTGS2—brain—malaria	0.000597	0.00559	CbGeAlD
Betamethasone—ABCB1—blood—malaria	0.000595	0.00557	CbGeAlD
Betamethasone—Decreased appetite—Sulfadiazine—malaria	0.000585	0.00231	CcSEcCtD
Betamethasone—Eye disorder—Quinidine barbiturate—malaria	0.000583	0.0023	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Sulfadiazine—malaria	0.000581	0.00229	CcSEcCtD
Betamethasone—ABCB1—bone marrow—malaria	0.000576	0.00539	CbGeAlD
Betamethasone—Vertigo—Dapsone—malaria	0.00057	0.00225	CcSEcCtD
Betamethasone—Arrhythmia—Pentoxifylline—malaria	0.000557	0.0022	CcSEcCtD
Betamethasone—Vertigo—Clindamycin—malaria	0.000551	0.00218	CcSEcCtD
Betamethasone—Angioedema—Quinine—malaria	0.00055	0.00217	CcSEcCtD
Betamethasone—Angioedema—Quinidine—malaria	0.00055	0.00217	CcSEcCtD
Betamethasone—Gastrointestinal pain—Sulfadiazine—malaria	0.00055	0.00217	CcSEcCtD
Betamethasone—Erythema—Quinidine barbiturate—malaria	0.000543	0.00215	CcSEcCtD
Betamethasone—Erythema—Pentoxifylline—malaria	0.000542	0.00214	CcSEcCtD
Betamethasone—Vertigo—Quinine—malaria	0.000541	0.00214	CcSEcCtD
Betamethasone—Vertigo—Quinidine—malaria	0.000541	0.00214	CcSEcCtD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—MPG—malaria	0.00054	0.0662	CbGpPWpGaD
Betamethasone—Syncope—Quinine—malaria	0.00054	0.00213	CcSEcCtD
Betamethasone—Syncope—Quinidine—malaria	0.00054	0.00213	CcSEcCtD
Betamethasone—Urticaria—Sulfadiazine—malaria	0.000534	0.00211	CcSEcCtD
Betamethasone—Abdominal pain—Sulfadiazine—malaria	0.000532	0.0021	CcSEcCtD
Betamethasone—Body temperature increased—Sulfadiazine—malaria	0.000532	0.0021	CcSEcCtD
Betamethasone—Hypertension—Clindamycin—malaria	0.00053	0.00209	CcSEcCtD
Betamethasone—Loss of consciousness—Quinidine—malaria	0.000529	0.00209	CcSEcCtD
Betamethasone—Loss of consciousness—Quinine—malaria	0.000529	0.00209	CcSEcCtD
Betamethasone—Convulsion—Quinine—malaria	0.000522	0.00206	CcSEcCtD
Betamethasone—Convulsion—Quinidine—malaria	0.000522	0.00206	CcSEcCtD
Betamethasone—Discomfort—Clindamycin—malaria	0.000516	0.00204	CcSEcCtD
Betamethasone—Myalgia—Quinine—malaria	0.000513	0.00202	CcSEcCtD
Betamethasone—Myalgia—Quinidine—malaria	0.000513	0.00202	CcSEcCtD
Betamethasone—Tachycardia—Dapsone—malaria	0.000505	0.002	CcSEcCtD
Betamethasone—Ill-defined disorder—Pentoxifylline—malaria	0.000503	0.00199	CcSEcCtD
Betamethasone—Anaphylactic shock—Clindamycin—malaria	0.000501	0.00198	CcSEcCtD
Betamethasone—Angioedema—Quinidine barbiturate—malaria	0.000497	0.00196	CcSEcCtD
Betamethasone—Angioedema—Pentoxifylline—malaria	0.000496	0.00196	CcSEcCtD
Betamethasone—Oedema—Quinine—malaria	0.000491	0.00194	CcSEcCtD
Betamethasone—Oedema—Quinidine—malaria	0.000491	0.00194	CcSEcCtD
Betamethasone—Thrombocytopenia—Clindamycin—malaria	0.00049	0.00194	CcSEcCtD
Betamethasone—Malaise—Pentoxifylline—malaria	0.000489	0.00193	CcSEcCtD
Betamethasone—Vertigo—Quinidine barbiturate—malaria	0.000488	0.00193	CcSEcCtD
Betamethasone—Syncope—Quinidine barbiturate—malaria	0.000487	0.00192	CcSEcCtD
Betamethasone—Shock—Quinidine—malaria	0.000484	0.00191	CcSEcCtD
Betamethasone—Shock—Quinine—malaria	0.000484	0.00191	CcSEcCtD
Betamethasone—Nervous system disorder—Quinidine—malaria	0.000482	0.0019	CcSEcCtD
Betamethasone—Nervous system disorder—Quinine—malaria	0.000482	0.0019	CcSEcCtD
Betamethasone—Thrombocytopenia—Quinine—malaria	0.000481	0.0019	CcSEcCtD
Betamethasone—Thrombocytopenia—Quinidine—malaria	0.000481	0.0019	CcSEcCtD
Betamethasone—Tachycardia—Quinidine—malaria	0.00048	0.00189	CcSEcCtD
Betamethasone—Tachycardia—Quinine—malaria	0.00048	0.00189	CcSEcCtD
Betamethasone—Loss of consciousness—Quinidine barbiturate—malaria	0.000478	0.00189	CcSEcCtD
Betamethasone—Pruritus—Sulfadiazine—malaria	0.000476	0.00188	CcSEcCtD
Betamethasone—Hyperhidrosis—Quinidine—malaria	0.000475	0.00188	CcSEcCtD
Betamethasone—Hyperhidrosis—Quinine—malaria	0.000475	0.00188	CcSEcCtD
Betamethasone—Convulsion—Quinidine barbiturate—malaria	0.000471	0.00186	CcSEcCtD
Betamethasone—Convulsion—Pentoxifylline—malaria	0.00047	0.00186	CcSEcCtD
Betamethasone—Anorexia—Quinidine—malaria	0.000468	0.00185	CcSEcCtD
Betamethasone—Anorexia—Quinine—malaria	0.000468	0.00185	CcSEcCtD
Betamethasone—Insomnia—Dapsone—malaria	0.000468	0.00185	CcSEcCtD
Betamethasone—Hypertension—Pentoxifylline—malaria	0.000468	0.00185	CcSEcCtD
Betamethasone—Hypotension—Clindamycin—malaria	0.000468	0.00185	CcSEcCtD
Betamethasone—ABCB1—liver—malaria	0.000465	0.00436	CbGeAlD
Betamethasone—Myalgia—Quinidine barbiturate—malaria	0.000463	0.00183	CcSEcCtD
Betamethasone—Myalgia—Pentoxifylline—malaria	0.000462	0.00182	CcSEcCtD
Betamethasone—Anxiety—Quinidine barbiturate—malaria	0.000461	0.00182	CcSEcCtD
Betamethasone—Diarrhoea—Sulfadiazine—malaria	0.00046	0.00182	CcSEcCtD
Betamethasone—Anxiety—Pentoxifylline—malaria	0.00046	0.00182	CcSEcCtD
Betamethasone—Hypotension—Quinine—malaria	0.000459	0.00181	CcSEcCtD
Betamethasone—Hypotension—Quinidine—malaria	0.000459	0.00181	CcSEcCtD
Betamethasone—Discomfort—Pentoxifylline—malaria	0.000456	0.0018	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Quinidine—malaria	0.000448	0.00177	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Quinine—malaria	0.000448	0.00177	CcSEcCtD
Betamethasone—Oedema—Quinidine barbiturate—malaria	0.000444	0.00175	CcSEcCtD
Betamethasone—Oedema—Pentoxifylline—malaria	0.000443	0.00175	CcSEcCtD
Betamethasone—Anaphylactic shock—Pentoxifylline—malaria	0.000443	0.00175	CcSEcCtD
Betamethasone—Dyspepsia—Clindamycin—malaria	0.000441	0.00174	CcSEcCtD
Betamethasone—Infection—Pentoxifylline—malaria	0.00044	0.00174	CcSEcCtD
Betamethasone—Shock—Quinidine barbiturate—malaria	0.000436	0.00172	CcSEcCtD
Betamethasone—Shock—Pentoxifylline—malaria	0.000436	0.00172	CcSEcCtD
Betamethasone—Nervous system disorder—Quinidine barbiturate—malaria	0.000435	0.00172	CcSEcCtD
Betamethasone—Thrombocytopenia—Quinidine barbiturate—malaria	0.000434	0.00171	CcSEcCtD
Betamethasone—Thrombocytopenia—Pentoxifylline—malaria	0.000433	0.00171	CcSEcCtD
Betamethasone—Tachycardia—Quinidine barbiturate—malaria	0.000433	0.00171	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Clindamycin—malaria	0.000432	0.00171	CcSEcCtD
Betamethasone—Tachycardia—Pentoxifylline—malaria	0.000432	0.00171	CcSEcCtD
Betamethasone—Fatigue—Clindamycin—malaria	0.000432	0.0017	CcSEcCtD
Betamethasone—Hyperhidrosis—Quinidine barbiturate—malaria	0.000429	0.00169	CcSEcCtD
Betamethasone—Pain—Clindamycin—malaria	0.000428	0.00169	CcSEcCtD
Betamethasone—Hyperhidrosis—Pentoxifylline—malaria	0.000428	0.00169	CcSEcCtD
Betamethasone—Vomiting—Sulfadiazine—malaria	0.000428	0.00169	CcSEcCtD
Betamethasone—Decreased appetite—Quinidine—malaria	0.000427	0.00169	CcSEcCtD
Betamethasone—Decreased appetite—Quinine—malaria	0.000427	0.00169	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Quinidine—malaria	0.000424	0.00167	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Quinine—malaria	0.000424	0.00167	CcSEcCtD
Betamethasone—Rash—Sulfadiazine—malaria	0.000424	0.00167	CcSEcCtD
Betamethasone—Dermatitis—Sulfadiazine—malaria	0.000424	0.00167	CcSEcCtD
Betamethasone—Gastrointestinal pain—Dapsone—malaria	0.000423	0.00167	CcSEcCtD
Betamethasone—Anorexia—Quinidine barbiturate—malaria	0.000423	0.00167	CcSEcCtD
Betamethasone—Anorexia—Pentoxifylline—malaria	0.000422	0.00167	CcSEcCtD
Betamethasone—Headache—Sulfadiazine—malaria	0.000421	0.00166	CcSEcCtD
Betamethasone—Hypotension—Quinidine barbiturate—malaria	0.000414	0.00164	CcSEcCtD
Betamethasone—Hypotension—Pentoxifylline—malaria	0.000414	0.00163	CcSEcCtD
Betamethasone—Gastrointestinal pain—Clindamycin—malaria	0.00041	0.00162	CcSEcCtD
Betamethasone—Abdominal pain—Dapsone—malaria	0.000409	0.00162	CcSEcCtD
Betamethasone—Body temperature increased—Dapsone—malaria	0.000409	0.00162	CcSEcCtD
Betamethasone—Feeling abnormal—Quinidine—malaria	0.000405	0.0016	CcSEcCtD
Betamethasone—Feeling abnormal—Quinine—malaria	0.000405	0.0016	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000404	0.0016	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000403	0.00159	CcSEcCtD
Betamethasone—Gastrointestinal pain—Quinidine—malaria	0.000402	0.00159	CcSEcCtD
Betamethasone—Gastrointestinal pain—Quinine—malaria	0.000402	0.00159	CcSEcCtD
Betamethasone—Insomnia—Pentoxifylline—malaria	0.0004	0.00158	CcSEcCtD
Betamethasone—Nausea—Sulfadiazine—malaria	0.0004	0.00158	CcSEcCtD
Betamethasone—Urticaria—Clindamycin—malaria	0.000398	0.00157	CcSEcCtD
Betamethasone—Abdominal pain—Clindamycin—malaria	0.000396	0.00156	CcSEcCtD
Betamethasone—Body temperature increased—Clindamycin—malaria	0.000396	0.00156	CcSEcCtD
Betamethasone—Urticaria—Quinidine—malaria	0.00039	0.00154	CcSEcCtD
Betamethasone—Urticaria—Quinine—malaria	0.00039	0.00154	CcSEcCtD
Betamethasone—Dyspepsia—Pentoxifylline—malaria	0.00039	0.00154	CcSEcCtD
Betamethasone—Abdominal pain—Quinidine—malaria	0.000388	0.00153	CcSEcCtD
Betamethasone—Body temperature increased—Quinidine—malaria	0.000388	0.00153	CcSEcCtD
Betamethasone—Abdominal pain—Quinine—malaria	0.000388	0.00153	CcSEcCtD
Betamethasone—Body temperature increased—Quinine—malaria	0.000388	0.00153	CcSEcCtD
Betamethasone—Decreased appetite—Quinidine barbiturate—malaria	0.000386	0.00152	CcSEcCtD
Betamethasone—Decreased appetite—Pentoxifylline—malaria	0.000385	0.00152	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000383	0.00151	CcSEcCtD
Betamethasone—Pain—Quinidine barbiturate—malaria	0.000379	0.0015	CcSEcCtD
Betamethasone—ABCB1—brain—malaria	0.000369	0.00346	CbGeAlD
Betamethasone—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.000367	0.0449	CbGpPWpGaD
Betamethasone—Feeling abnormal—Quinidine barbiturate—malaria	0.000365	0.00144	CcSEcCtD
Betamethasone—Feeling abnormal—Pentoxifylline—malaria	0.000365	0.00144	CcSEcCtD
Betamethasone—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000363	0.00143	CcSEcCtD
Betamethasone—Gastrointestinal pain—Pentoxifylline—malaria	0.000362	0.00143	CcSEcCtD
Betamethasone—PGR—Cellular roles of Anthrax toxin—IL18—malaria	0.000361	0.0443	CbGpPWpGaD
Betamethasone—Asthenia—Clindamycin—malaria	0.000359	0.00142	CcSEcCtD
Betamethasone—Pruritus—Clindamycin—malaria	0.000354	0.0014	CcSEcCtD
Betamethasone—Asthenia—Quinine—malaria	0.000353	0.00139	CcSEcCtD
Betamethasone—Asthenia—Quinidine—malaria	0.000353	0.00139	CcSEcCtD
Betamethasone—Urticaria—Quinidine barbiturate—malaria	0.000352	0.00139	CcSEcCtD
Betamethasone—Urticaria—Pentoxifylline—malaria	0.000352	0.00139	CcSEcCtD
Betamethasone—Body temperature increased—Quinidine barbiturate—malaria	0.000351	0.00138	CcSEcCtD
Betamethasone—Abdominal pain—Quinidine barbiturate—malaria	0.000351	0.00138	CcSEcCtD
Betamethasone—Body temperature increased—Pentoxifylline—malaria	0.00035	0.00138	CcSEcCtD
Betamethasone—Abdominal pain—Pentoxifylline—malaria	0.00035	0.00138	CcSEcCtD
Betamethasone—Pruritus—Quinidine—malaria	0.000348	0.00137	CcSEcCtD
Betamethasone—Pruritus—Quinine—malaria	0.000348	0.00137	CcSEcCtD
Betamethasone—Diarrhoea—Clindamycin—malaria	0.000343	0.00135	CcSEcCtD
Betamethasone—Diarrhoea—Quinidine—malaria	0.000336	0.00133	CcSEcCtD
Betamethasone—Diarrhoea—Quinine—malaria	0.000336	0.00133	CcSEcCtD
Betamethasone—Dizziness—Clindamycin—malaria	0.000331	0.00131	CcSEcCtD
Betamethasone—Vomiting—Dapsone—malaria	0.000329	0.0013	CcSEcCtD
Betamethasone—Dizziness—Quinidine—malaria	0.000325	0.00128	CcSEcCtD
Betamethasone—Dizziness—Quinine—malaria	0.000325	0.00128	CcSEcCtD
Betamethasone—Headache—Dapsone—malaria	0.000324	0.00128	CcSEcCtD
Betamethasone—Vomiting—Clindamycin—malaria	0.000319	0.00126	CcSEcCtD
Betamethasone—Asthenia—Quinidine barbiturate—malaria	0.000318	0.00126	CcSEcCtD
Betamethasone—Asthenia—Pentoxifylline—malaria	0.000318	0.00125	CcSEcCtD
Betamethasone—Rash—Clindamycin—malaria	0.000316	0.00125	CcSEcCtD
Betamethasone—Dermatitis—Clindamycin—malaria	0.000316	0.00125	CcSEcCtD
Betamethasone—Headache—Clindamycin—malaria	0.000314	0.00124	CcSEcCtD
Betamethasone—Pruritus—Quinidine barbiturate—malaria	0.000314	0.00124	CcSEcCtD
Betamethasone—Pruritus—Pentoxifylline—malaria	0.000313	0.00124	CcSEcCtD
Betamethasone—Vomiting—Quinidine—malaria	0.000312	0.00123	CcSEcCtD
Betamethasone—Vomiting—Quinine—malaria	0.000312	0.00123	CcSEcCtD
Betamethasone—Rash—Quinine—malaria	0.00031	0.00122	CcSEcCtD
Betamethasone—Rash—Quinidine—malaria	0.00031	0.00122	CcSEcCtD
Betamethasone—Dermatitis—Quinidine—malaria	0.00031	0.00122	CcSEcCtD
Betamethasone—Dermatitis—Quinine—malaria	0.00031	0.00122	CcSEcCtD
Betamethasone—Headache—Quinidine—malaria	0.000308	0.00122	CcSEcCtD
Betamethasone—Headache—Quinine—malaria	0.000308	0.00122	CcSEcCtD
Betamethasone—Nausea—Dapsone—malaria	0.000308	0.00121	CcSEcCtD
Betamethasone—Diarrhoea—Quinidine barbiturate—malaria	0.000303	0.0012	CcSEcCtD
Betamethasone—Diarrhoea—Pentoxifylline—malaria	0.000303	0.0012	CcSEcCtD
Betamethasone—Nausea—Clindamycin—malaria	0.000298	0.00117	CcSEcCtD
Betamethasone—Dizziness—Quinidine barbiturate—malaria	0.000293	0.00116	CcSEcCtD
Betamethasone—Dizziness—Pentoxifylline—malaria	0.000293	0.00116	CcSEcCtD
Betamethasone—Nausea—Quinidine—malaria	0.000292	0.00115	CcSEcCtD
Betamethasone—Nausea—Quinine—malaria	0.000292	0.00115	CcSEcCtD
Betamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—PKLR—malaria	0.000285	0.0349	CbGpPWpGaD
Betamethasone—Vomiting—Quinidine barbiturate—malaria	0.000282	0.00111	CcSEcCtD
Betamethasone—Vomiting—Pentoxifylline—malaria	0.000281	0.00111	CcSEcCtD
Betamethasone—Rash—Quinidine barbiturate—malaria	0.00028	0.0011	CcSEcCtD
Betamethasone—Dermatitis—Quinidine barbiturate—malaria	0.000279	0.0011	CcSEcCtD
Betamethasone—Rash—Pentoxifylline—malaria	0.000279	0.0011	CcSEcCtD
Betamethasone—Dermatitis—Pentoxifylline—malaria	0.000279	0.0011	CcSEcCtD
Betamethasone—Headache—Quinidine barbiturate—malaria	0.000278	0.0011	CcSEcCtD
Betamethasone—Headache—Pentoxifylline—malaria	0.000277	0.00109	CcSEcCtD
Betamethasone—Nausea—Quinidine barbiturate—malaria	0.000263	0.00104	CcSEcCtD
Betamethasone—Nausea—Pentoxifylline—malaria	0.000263	0.00104	CcSEcCtD
Betamethasone—PGR—Cellular roles of Anthrax toxin—IL1B—malaria	0.000189	0.0231	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—CRP—malaria	0.000149	0.0183	CbGpPWpGaD
Betamethasone—PTGS2—S1P1 pathway—KDR—malaria	0.000143	0.0175	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000142	0.0173	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000142	0.0173	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—HBB—malaria	0.000139	0.017	CbGpPWpGaD
Betamethasone—PGR—Cellular roles of Anthrax toxin—TNF—malaria	0.000137	0.0168	CbGpPWpGaD
Betamethasone—PTGS2—Arachidonic acid metabolism—HPGDS—malaria	0.000132	0.0162	CbGpPWpGaD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	0.000126	0.0155	CbGpPWpGaD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	0.000123	0.0151	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	8.34e-05	0.0102	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL10—malaria	8.25e-05	0.0101	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	8.18e-05	0.01	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	8.15e-05	0.00999	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL4—malaria	8.02e-05	0.00982	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	7.96e-05	0.00974	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—malaria	7.92e-05	0.0097	CbGpPWpGaD
Betamethasone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	7.89e-05	0.00966	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—DHODH—malaria	7.88e-05	0.00965	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—HPGDS—malaria	7.75e-05	0.0095	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	7.73e-05	0.00947	CbGpPWpGaD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	7.44e-05	0.00911	CbGpPWpGaD
Betamethasone—CYP19A1—Biological oxidations—HPGDS—malaria	7.37e-05	0.00903	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—malaria	7.34e-05	0.00898	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—SCARB1—malaria	7.12e-05	0.00872	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL4—malaria	7.07e-05	0.00865	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—TNF—malaria	6.75e-05	0.00827	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—SLC4A1—malaria	6.7e-05	0.00821	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—FCGR2A—malaria	6.66e-05	0.00816	CbGpPWpGaD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	6.61e-05	0.00809	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—malaria	6.39e-05	0.00783	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—DECR1—malaria	6.3e-05	0.00772	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—HBB—malaria	5.7e-05	0.00698	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—malaria	5.61e-05	0.00687	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL12B—malaria	5.5e-05	0.00673	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—IL6—malaria	5.45e-05	0.00667	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—DECR1—malaria	5.17e-05	0.00633	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PKLR—malaria	5.08e-05	0.00622	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IFNG—malaria	4.85e-05	0.00594	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	4.81e-05	0.00589	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	4.53e-05	0.00555	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—G6PD—malaria	4.53e-05	0.00554	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—FAS—malaria	4.5e-05	0.00552	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CD36—malaria	4.47e-05	0.00547	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—CRP—malaria	4.37e-05	0.00536	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL10—malaria	4.34e-05	0.00532	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL2—malaria	4.31e-05	0.00528	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	4.27e-05	0.00523	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—malaria	4.27e-05	0.00523	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	4.02e-05	0.00492	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CD40LG—malaria	4.02e-05	0.00492	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL10—malaria	4.02e-05	0.00492	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL4—malaria	4e-05	0.0049	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL4—malaria	3.91e-05	0.00479	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—HLA-B—malaria	3.82e-05	0.00468	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—malaria	3.8e-05	0.00465	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—FAS—malaria	3.6e-05	0.00441	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	3.56e-05	0.00436	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—HPGDS—malaria	3.45e-05	0.00423	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	3.45e-05	0.00423	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	3.33e-05	0.00407	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TLR4—malaria	3.32e-05	0.00406	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	3.21e-05	0.00393	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—DHFR—malaria	3.2e-05	0.00392	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—ICAM1—malaria	3.18e-05	0.00389	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—SCARB1—malaria	3.17e-05	0.00388	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—NOS2—malaria	3.16e-05	0.00386	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	3.11e-05	0.00381	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CD4—malaria	3.07e-05	0.00376	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IFNG—malaria	3.06e-05	0.00375	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—DHODH—malaria	2.88e-05	0.00353	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.83e-05	0.00347	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL1B—malaria	2.73e-05	0.00334	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.6e-05	0.00318	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL6—malaria	2.53e-05	0.0031	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	2.51e-05	0.00307	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ACKR1—malaria	2.5e-05	0.00306	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	2.48e-05	0.00303	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SLC4A1—malaria	2.45e-05	0.003	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IFNG—malaria	2.42e-05	0.00296	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IFNG—malaria	2.36e-05	0.0029	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—IL6—malaria	2.36e-05	0.00289	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—DECR1—malaria	2.3e-05	0.00282	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL1B—malaria	2.28e-05	0.00279	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—malaria	2.23e-05	0.00273	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL1B—malaria	2.16e-05	0.00264	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—HPGDS—malaria	2.15e-05	0.00264	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL2—malaria	2.15e-05	0.00263	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL1B—malaria	2.11e-05	0.00258	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL2—malaria	2.1e-05	0.00257	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—HBB—malaria	2.08e-05	0.00255	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TLR9—malaria	2.01e-05	0.00246	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CD36—malaria	1.99e-05	0.00244	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—TNF—malaria	1.98e-05	0.00243	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—DHODH—malaria	1.92e-05	0.00236	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TNF—malaria	1.91e-05	0.00234	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.89e-05	0.00232	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PKLR—malaria	1.86e-05	0.00227	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	1.78e-05	0.00218	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.74e-05	0.00213	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—G6PD—malaria	1.65e-05	0.00202	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—malaria	1.65e-05	0.00202	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC4A1—malaria	1.64e-05	0.002	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CD36—malaria	1.63e-05	0.002	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL6—malaria	1.6e-05	0.00196	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TNF—malaria	1.57e-05	0.00192	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—IL6—malaria	1.54e-05	0.00189	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—DECR1—malaria	1.54e-05	0.00188	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TNF—malaria	1.53e-05	0.00187	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PKLR—malaria	1.48e-05	0.00181	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HBB—malaria	1.39e-05	0.0017	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—DHODH—malaria	1.36e-05	0.00167	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—malaria	1.33e-05	0.00163	CbGpPWpGaD
Betamethasone—PTGS2—Disease—G6PD—malaria	1.32e-05	0.00162	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL6—malaria	1.26e-05	0.00155	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—HPGDS—malaria	1.26e-05	0.00154	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PKLR—malaria	1.24e-05	0.00152	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—DHFR—malaria	1.17e-05	0.00143	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC4A1—malaria	1.16e-05	0.00142	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SCARB1—malaria	1.16e-05	0.00142	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—G6PD—malaria	1.1e-05	0.00135	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	1.09e-05	0.00133	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—DECR1—malaria	1.09e-05	0.00133	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.07e-05	0.0013	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HBB—malaria	9.86e-06	0.00121	CbGpPWpGaD
Betamethasone—PTGS2—Disease—DHFR—malaria	9.33e-06	0.00114	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PKLR—malaria	8.79e-06	0.00108	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HPGDS—malaria	8.43e-06	0.00103	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—DHODH—malaria	8.4e-06	0.00103	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KDR—malaria	8.01e-06	0.000981	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—G6PD—malaria	7.83e-06	0.000959	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—DHFR—malaria	7.82e-06	0.000957	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SCARB1—malaria	7.74e-06	0.000947	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	7.55e-06	0.000925	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CD36—malaria	7.27e-06	0.00089	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC4A1—malaria	7.14e-06	0.000875	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—DECR1—malaria	6.72e-06	0.000822	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HBB—malaria	6.07e-06	0.000744	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HPGDS—malaria	5.97e-06	0.000731	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—DHFR—malaria	5.54e-06	0.000679	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SCARB1—malaria	5.48e-06	0.000672	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PKLR—malaria	5.41e-06	0.000663	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2—malaria	5.19e-06	0.000636	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CD36—malaria	4.86e-06	0.000595	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—G6PD—malaria	4.83e-06	0.000591	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS2—malaria	4.77e-06	0.000584	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HPGDS—malaria	3.68e-06	0.000451	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD4—malaria	3.53e-06	0.000432	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CD36—malaria	3.44e-06	0.000421	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—DHFR—malaria	3.41e-06	0.000418	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SCARB1—malaria	3.38e-06	0.000414	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—malaria	3.05e-06	0.000374	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CD36—malaria	2.12e-06	0.00026	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—malaria	1.91e-06	0.000234	CbGpPWpGaD
